Sanofi SA (SNY)'s New Diabetes Play Moves Forward
Sanofi SA (ADR) (NYSE:SNY) starts the week with a new European Union approval for the type 2 diabetes injectable Lyxumia.
February 4th, 2013 - News
February 1st, 2013 - News
February 1st, 2013 - News
January 22nd, 2013 - News
Returns since its inception in May 2014 (through February 19th, 2025)